Fate Therapeutics (FATE) Times Interest Earned (2013 - 2019)
Fate Therapeutics (FATE) reported Times Interest Earned of -$48.46 for Q4 2019, down 24.48% on a YoY basis from -$64.17 in Q4 2018, and up 28.52% quarter-over-quarter from -$67.8 in Q3 2019.
Fate Therapeutics (FATE) Times Interest Earned (2013 - 2019) Analysis & Trends
Fate Therapeutics has reported Times Interest Earned for 7 years, with the latest figure at -$48.46 in Q4 2019.
- For the quarter ending Q4 2019, Times Interest Earned fell 24.48% year-over-year to -$48.46; the trailing twelve-month figure through Sep 2020 stood at -$206.27 (down 281.56% YoY), and the FY2019 full-year result was -$55.96, down 41.46% from the prior year.
- Times Interest Earned for Q4 2019 stood at -$48.46, up from -$67.8 in the prior quarter.
- The five-year high for Times Interest Earned was -$10.55 in Q3 2015, with the low at -$67.8 in Q3 2019.
- Historically, Times Interest Earned has averaged -$32.67 across 5 years, with a median of -$31.92 in 2017.
- Annual changes were most pronounced in 2015 — Times Interest Earned jumped 94.06% — and 2017, when it sank 145.33%.
- Fate Therapeutics' Times Interest Earned stood at -$12.87 in 2015, then plunged by 80.74% to -$23.26 in 2016, then declined by 27.74% to -$29.72 in 2017, then sank by 31.0% to -$38.93 in 2018, then retreated by 24.48% to -$48.46 in 2019.
- The last three Times Interest Earned figures came in at -$48.46 (Q4 2019), -$67.8 (Q3 2019), and -$60.21 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -48.46 |
| Sep 30, 2019 | -67.80 |
| Jun 30, 2019 | -60.21 |
| Mar 31, 2019 | -50.48 |
| Dec 31, 2018 | -38.93 |
| Sep 30, 2018 | -38.91 |
| Jun 30, 2018 | -46.13 |
| Mar 31, 2018 | -34.11 |
| Dec 31, 2017 | -29.72 |
| Sep 30, 2017 | -27.35 |
| Jun 30, 2017 | -45.14 |
| Mar 31, 2017 | -37.48 |
| Dec 31, 2016 | -23.26 |
| Sep 30, 2016 | -21.79 |
| Jun 30, 2016 | -18.40 |
| Mar 31, 2016 | -15.83 |
| Dec 31, 2015 | -12.87 |
| Sep 30, 2015 | -10.55 |
| Jun 30, 2015 | -12.82 |
| Mar 31, 2015 | -13.13 |